RACK1 is one of a group of PKC-interacting proteins collectively called RACKs (Receptors for Activated CKinases). Previously, we showed that RACK1 also interacts with the Src tyrosine kinase, and is an inhibitor of Src activity and cell growth. PKC activation induces the intracellular movement and co-localization of RACK1 and Src, and the tyrosine phosphorylation of RACK1. To determine whether RACK1 is a Src substrate, we assessed phosphorylation of RACK1 by various tyrosine kinases in vitro, and by kinase-active and inactive mutants of Src in vivo. We found that RACK1 is a Src substrate. Moreover, Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation. To identify the tyrosine(s) on RACK1 that is phosphorylated by Src, we generated and tested a series of RACK1 mutants. We found that Src phosphorylates RACK1 on Tyr 228 and/ or Tyr 246, highly-conserved tyrosines located in the sixth WD repeat that interact with Src's SH2 domain. We think that RACK1 is an important Src substrate that signals downstream of growth factor receptor tyrosine kinases and is involved in the regulation of Src function and cell growth.
Introduction
The Src tyrosine kinase participates in diverse signaling pathways that regulate diverse cellular functions. These include proliferation, differentiation, motility and adhesion (reviewed in Martin, 2001; Thomas and Brugge, 1997; Abram and Courtneidge, 2000) . The subcellular localization of Src may determine, in part, its substrate specificity and function. For example, if Src is localized to the plasma membrane it may phosphorylate proteins that function in mitogenic signaling via growth factor receptor-tyrosine kinases, or in cell adhesion, cell migration or cell -cell interactions. In contrast, if Src is localized to endosomal membranes it may target proteins involved in intracellular trafficking or transport; or if Src is localized to the perinuclear membrane, it may target proteins involved in cell cycle regulation. Thus, by identifying distinct substrates of Src within distinct subcellular compartments, we will learn about specific functions of Src.
One example of a Src substrate, whose phosphorylation by Src appears to determine specific functions of Src, is Sam68, an RNA binding protein (reviewed in Thomas and Brugge, 1997; Bjorge et al., 2000) . Src phosphorylates Sam68 during mitosis, presumably after breakdown of the nuclear envelope. Src appears to be important for regulating cell cycle progression via Sam68, particularly during the late states of mitosis and possibly during the G1/S transition. Evidence is also emerging that Src may regulate gene expression at the post-transcriptional level via Sam68 and that Src can regulate mRNA splicing and/or transport (reviewed in Bjorge et al., 2000) . Thus, identification and characterization of a single Src substrate has provided important information about the function of Src in regulating cell cycle progression and gene expression.
RACK1 (Receptor for Activated C Kinase) was the first of a group of protein kinase C (PKC)-interacting proteins that have been identified and characterized (reviewed in Mochly-Rosen, 1995; Mochly-Rosen and Kauvar, 1998; Schechtman and Mochly-Rosen, 2001 ). Using the yeast two-hybrid assay, we identified RACK1 as a novel Src-binding protein and a novel inhibitor of Src activity and cell growth . While a number of interacting proteins have been identified that upregulate Src activity, few have been identified that downregulate Src activity. Because it is the repression of c-Src activity rather than the elevation of v-Src activity that accounts for differences is the transforming abilities of the two kinases, it is important to search for cellular mechanisms that inactive c-Src. In doing so, we will learn about mechanism by which normal cells regulate their growth.
Previously, we found that PKC activation induces the intracellular movement and co-localization of RACK1 and Src at the plasma membrane, and the tyrosine phosphorylation of RACK1 . Together, these findings suggested that RACK1 is a Src substrate. However, Src is only one of many tyrosine kinases that could potentially phosphorylate RACK1 in cells. The purpose of this study was to determine whether RACK1 is a Src substrate, and if so, to identify the site(s) on RACK1 phosphorylated by Src. Using kinase active and inactive mutants of Src, we found that RACK1 is a Src substrate. Moreover, Src activity is necessary for both the tyrosine phosphorylation and the binding of RACK1 to Src's SH2 domain that occur following PKC activation. Using mutants of RACK1 that contained phenylalanine substitutions for tyrosines, we found that Src phosphorylates RACK1 on Tyr 228 and/or Tyr 246, highly-conserved tyrosines located in the sixth WD repeat that interact with Src's SH2 domain.
Results

RACK1
is an in vitro substrate for Src and not for the Abl, EGFR or PDGFR tyrosine kinases Previously, we found that RACK1 is phosphorylated on tyrosine . We also found that PKC activation induces the intracellular movement and co-localization of RACK1 and Src, and the tyrosine phosphorylation of RACK1. These findings suggested that Src is one tyrosine kinase that phosphorylates RACK1. To identify tyrosine kinases that phosphorylate RACK1 in vitro, we incubated equivalent amounts of purified GST or GST -RACK1 with purified Src (expressed from recombinant baculovirus and purified from Sf9 cells), Abl, EGFR or PDGFR tyrosine kinase (normalized to equivalent amounts of specific activity) and performed in vitro protein-kinase assays in the presence of MnCl 2 , MgCl 2 and [g-32 P]ATP ( Figure 1a ). As expected, we observed autophosphorylation of all of the tyrosine kinases. In addition, we found that Src phosphorylated GST -RACK1 ( Figure 1a , lane 4) to higher stoichiometry than did the other tyrosine kinases tested. Src also phosphorylated GST (Figure 1a , lane 3), but at significantly lower levels than it phosphorylated GST -RACK1. To determine whether Src was phosphorylating RACK1 or the GST portion of the fusion protein, we proteolytically-cleaved RACK1 from GST -RACK1 using thrombin, incubated the purified RACK1 with Src and performed an in vitro kinase assay. We observed phosphorylation of the purified RACK1 by Src (data not shown). Therefore, under the conditions that we used, Src phosphorylates RACK1 in vitro, whereas the other non-receptor and receptor tyrosine kinases that we tested, do not. Interestingly, the Abl tyrosine kinase, which is evolutionarily close to Src in terms of catalytic-domain substrate specificity, did not phosphorylate GST -RACK1 (Figure 1a , lane 6). Previously, we showed that the Abl SH2 domain does not binds to GST -RACK1 either .
To determine whether immunoprecipitates of Src phosphorylate GST -RACK1, and whether the specific activity of Src affects its ability to phosphorylate RACK1, we immunoprecipitated similar amounts of Src protein from NIH3T3 cells overexpressing Y527F c-Src (a partially activated and transforming c-Src mutant) or wild-type c-Src, incubated immunoprecipitates with GST or GST -RACK1 and performed in vitro kinase assays (Figure 1b) . We found that immunoprecipitates of Y527F Src phosphorylated GST -RACK1 ( Figure 1b , lane 2) but not GST (Figure 1b, lane 1) . A longer exposure of the autoradiogram (not shown) revealed that immunoprecipitates of wild-type Src also phosphorylated GST -RACK1, although at significantly lower levels than did those of Y527F Src. As expected, we observed autophosphorylation of Y527F and wild-type Src ( Figure 1b, lanes 1 -4) . The amount of Src present in each immunoprecipitate was similar (Figure 1b, lanes  8 -10) . Thus, immunoprecipitates of Src phosphorylate Figure 1 Phosphorylation of RACK1 by Src in vitro. (a) Phosphorylation of GST -RACK1 by purified receptor and non-receptor tyrosine kinases. Purified EGFR (lanes 1 and 2), Src (lanes 3 and 4), Abl (lanes 5 and 6) or PDGFR (lanes 7 and 8) tyrosine kinases (normalized to equivalent amounts of specific activity) were incubated with equivalent amounts of purified GST (odd lanes) or GST -RACK1 (even lanes) and [g-32 P]ATP, MgCl 2 and MnCl 2 , for 10 min at 308C in an in vitro protein kinase assay.
32
P-labeled proteins were resolved by SDS -PAGE and visualized by autoradiography. Approximate molecular masses of the kinases (kDa): EGFR, 70; c-Src, 60; c-Abl, 150; PDGFR, 180. The smeared bands in lanes 5 and 6 may represents poor migration of the Abl kinase through the gel. RK, RACK1. (b) Phosphorylation of GST -RACK1 by Src immunoprecipitates. Proteins were immunoprecipitated with a monoclonal antibody specific for Src, or IgG (lane 7) from NIH3T3 cell lysates expressing Y527F c-Src (lanes 1, 2 and 8), wild-type c-Src (lanes 3, 4 and 9) or vector alone (lanes 5 -7 and 10). Immunoprecipitates of Src (lanes 1 -6), or IgG (lane 7), were incubated with equivalent amounts of purified GST (odd lanes) or GST -RACK1 (even lanes) and subjected to in vitro protein kinase assays as described in (a), or subjected to immunoblot analysis with anti- GST -RACK1, and immunoprecipitates of Src kinases that have elevated specific activity phosphorylate GST -RACK1 at higher levels than does normal c-Src.
RACK1 is an endogenous substrate for Src
To determine whether RACK1 is an endogenous substrate for Src, we assessed the tyrosine phosphorylation of RACK1 in cell lines that expressed Src with different levels of specific activity. We and others have been unsuccessful in attempts to generate antibodies that immunoprecipitate RACK1 efficiently from cell lysates. Thus, to study tyrosine-phosphorylated RACK1, we immunoprecipitate proteins with a monoclonal antibody that is specific for phosphotyrosine and perform immunoblot analyses with a monoclonal antibody that is specific for RACK1 . Using this approach, we made RIPA lysates of NIH3T3 cells, NIH3T3 cells that were expressing v-Src, or CHO cells that were expressing Y527F c-Src and HA -RACK1, immunoprecipitated proteins with anti-phosphotyrosine or IgG and performed immunoblot analysis with anti-RACK1 (Figure 2 ). Y527 c-Src was transiently expressed at significantly higher levels in the CHO cells than v-Src was stably expressed in the NIH3T3 cells (data not shown). HA -RACK1 contains a nine-amino acid, influenza virus hemagglutinin (HA)-tag; thus, it is approximately 1 kDa larger than endogenous RACK1. We detected tyrosine-phosphorylated endogenous RACK1 (arrowhead) and HA -RACK1 (arrow) in CHO cells that were overexpressingY527F Src and HA -RACK1 (Figure 2 We also tested the following c-Src kinases, each with a different level of specific activity, for their ability to phosphorylate and associate with endogenous RACK1: (1) Y527F c-Src, a partially activated and transforming c-Src mutant with a specific activity that is about onehalf that of v-Src Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987; Reynolds et al., 1987) ; (2) Y416F/Y527F c-Src, a partially activated c-Src mutant with a specific activity that is about one-half that of Y527F c-Src (Kmiecik and Shalloway, 1987) ; (3) Y416F c-Src, a c-Src mutant with a specific activity that is about one-tenth that of Y527F c-Src and about equal to that of wild-type c-Src (Kmiecik and Shalloway, 1987) ; and (4) Thus, endogenous RACK1 that had been phosphorylated by the c-Src mutants binds to Src's SH2 domain. Moreover, the higher the kinase activity of Src, the more tyrosine-phosphorylation of RACK1 that occurs (presumably by Src) , and the more tyrosine-phosphorylation of RACK1 that occurs, the more binding there is of RACK1 to Src. The higher levels of Src kinase activity could be due to higher specific activity of the kinase and/or to higher levels of Src protein expression. The higher levels of tyrosine-phosphorylated RACK1 detected could be due to phosphorylation of a greater number of RACK1 molecules and/or to phosphorylation of a greater number of tyrosines on individual RACK1 molecules. Together, the results from Figures 2 and 3 show that RACK1 is an endogenous substrate for Src. Moreover, endogenous RACK1 that has been phosphorylated by Src, binds to Src's SH2 domain.
Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation To determine whether Src activity is necessary for the tyrosine phosphorylation of RACK1 that occurs following PKC activation, we expressed HA -RACK1 or HA -RACK1 together with kinase-active or inactive Src mutants in CHO cells, treated cells with PMA for 15 min, immunoprecipitate proteins with anti-phosphotyrosine and performed immunoblot analysis with anti-RACK1 (Figure 4a ). We used three Src mutants: (1) Y527F c-Src (constitutively-active) ; (2) K297M Src (kinase-inactive) ; and (3) dl155 Src (contains a three amino acid deletion in the phosphotyrosine binding pocket of the SH2 domain) . Previously, we showed that the dl155 Src mutant has reduced binding to RACK1 . We observed the highest levels of tyrosine phosphorylation on RACK1 in cells expressing 13 and 14) . Thus, Src activity is necessary for the tyrosine phosphorylation of RACK1, because RACK1 is not phosphorylated by kinase-inactive Src. To determine whether Src activity is required for the binding of Figure 4b, lane 7) . In fact, the amount of RACK1 present in dl155 and K297M Src immunoprecipitates was not more than could be accounted for by endogenous Src (Figure 4b, lane 3) . As expected, RACK1 did not bind to IgG immunoprecipitates ( Figure 4b, lanes 8 -12) . The amount of Src present in each immunoprecipitate was similar (Figure 4c, lanes 3 -6) . Thus, Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation.
Src phosphorylates RACK1 in the carboxy-terminal region of the molecule
To begin identifying the Src phosphorylation site(s) on RACK1, we generated a series of N-or C-terminal truncated mutants of RACK1 (see Figure 6 ). Initially, we co-expressed the N-terminal mutants or full-length RACK1 together with Y527F c-Src and performed immunoblot analysis with anti-phosphotyrosine (Figure 5a ). RACK1 mutant 5.1 lacks amino acids 1 -41, 5.2 lacks amino acids 1 -93, and 5.3 lacks amino acids 1 -137. As expected, we observed more tyrosinephosphorylated proteins, and higher levels of tyrosinephosphorylation on proteins, in cells that were transfected with Y527F c-Src (Figure 5a , lanes 3 -6) than in cells that were not transfected with Src ( Figure  5a, lanes 1 and 2) . In cells expressing Y527F c-Src ( Figure 5a, lanes 3 -6) , we also observed a tyrosinephosphorylated protein with a molecular mass that was appropriate for endogenous RACK1. In cells expressing Y527F c-Src and full-length, wild-type HA -RACK1 (Figure 5a , lane 3), we detected a tyrosinephosphorylated protein that was slightly larger than endogenous RACK1 and had a molecular mass that was appropriate for HA -RACK1. In cells expressing Y527F c-Src and RACK1 -5.1 (Figure 5a , lane 4), we observed a tyrosine-phosphorylated protein with a molecular mass that was appropriate for a RACK1 protein lacking 41 amino acids. In cells expressing Y527F c-Src and RACK1 -5.2 (Figure 5a , lane 5), we observed a tyrosine-phosphorylated protein with a molecular mass that was appropriate for a RACK1 protein lacking 93 amino acids. Finally, in cells expressing Y527F c-Src and RACK1 -5.3 (Figure 5a , lane 6), we observed a tyrosine-phosphorylated protein with a molecular mass that was appropriate for a RACK1 protein lacking 137 amino acids. The blot was then stripped of antibody and re-probed with anti-RACK1 (Figure 5b ). We observed that the mobility of each RACK1 mutant was appropriate for its predicted molecular mass. Overlaying the autoradiograms from Figure 5a ,b revealed that the tyrosine-phosphorylated proteins that we thought were RACK1 proteins on the anti-phosphotyrosine blot were, in fact, RACK1 because they co-migrated with RACK1 on the anti-RACK1 blot. In a repeat experiment, the RACK1 -5.3 mutant was expressed at higher levels ( Figure 5d , lane 4) and was more clearly tyrosine-phosphorylated (Figure 5c, lane 4) . RACK1 -5.3 lacks WD repeats 1 -3 and contains WD repeats 4 -7 (see Figure 6) . Thus, Src phosphorylates RACK1 on a tyrosine(s) located in one of the four carboxy-terminal WD repeats.
Src phosphorylates RACK1 in the sixth WD repeat, on Tyr 228 and/or 246
To further identify the tyrosine(s) on RACK1 that is phosphorylated by Src, we expressed the N-or Cterminal truncated mutants of RACK1 as GST fusion proteins and tested them for phosphorylation by Src (which had been expressed in baculovirus and purified from Sf9 cells) in an in vitro kinase assay. The results are summarized schematically in Figure 6 (left column). We observed that all RACK1 mutants that retained the sixth WD repeat were phosphorylated by Src in vitro, whereas those that had lost this repeat were not.
Next, we tested the truncated RACK1 mutants for phosphorylation by Src in vivo. To do so, we coexpressed Src and the HA -RACK1 mutants transiently in CHO cells, treated cells with PMA for 15 min, immunoprecipitated proteins with anti-phosphotyrosine and performed immunoblot analysis with anti-RACK1. HA -RACK1 protein levels were measured by immunoblot analysis of cell lysates with anti-RACK1. Because the amount of mutant HA -RACK1 expressed in cells varied with each transfection, data were quantified by scanning densitometry of bands, expressed as a ratio of tyrosine-phosphorylated mutant HA -RACK1 to levels of mutant HA -RACK1 protein expressed in cells, and compared with the ratio for wild-type RACK1. We found that RACK1 mutants that contained the sixth WD repeat and were phosphorylated by Src in vitro, were also phosphorylated by Src in vivo ( Figure 6 , right column). In contrast, RACK1 mutants that lacked the sixth WD repeat and were not phosphorylated by Src in vitro, were not phosphorylated by Src in vivo. Thus, Src phosphorylates RACK1 on a tyrosine(s) located in the sixth WD repeat.
We also subjected lysates of cells expressing Cterminal truncation mutants of RACK1 to immunoblot analysis with anti-phosphotyrosine (Figure 6b , lanes 1 -6). In lysates containing wild-type RACK1 (1 -317), we detected a tyrosine-phosphorylated 36 kDa protein (Figure 6b, lane 6) , which is the predicted size for a full-length RACK1 protein. In lysates containing a RACK1 mutant that lacks WD repeat seven (1 -258), we detected a tyrosine-phosphorylated 28 kDa protein (Figure 6b, lane 5) , which is the predicted size for a RACK1 protein lacking 59 amino acids. However, in lysates containing a RACK1 mutant that lacks WD repeats six and seven (1 -225), we did not detect a tyrosine-phosphorylated 25 kDa protein (Figure 6b , lane 4), which is the predicted size for a RACK1 protein lacking 92 amino acids. Nor did we detect a tyrosine-phosphorylated 20 kDa protein in lysates containing a mutant that lacks repeats five -seven (1 -183; Figure 6b , lane 3), a tyrosine-phosphorylated 14 kDa protein in lysates containing a mutant that lacks repeats four -seven (1 -125; Figure 6b , lane 2) or a tyrosine-phosphorylated 11 kDa protein in lysates containing a mutants that lacks repeats three -seven (1 -97; Figure 6b , lane 1). Together, our results show that Src phosphorylates RACK1 on a tyrosine(s) located in the sixth WD repeat.
To identify the specific tyrosine(s) in RACK1 that is phosphorylated by Src in vivo, we performed sitedirected mutagenesis, substituting phenylalanine for tyrosine at individual and multiple sites in RACK1. The RACK1 mutants were then transiently coexpressed with Src in CHO cells and proteins were immunoprecipitated from RIPA lysates with antiphosphotyrosine and subjected to immunoblot analysis with anti-RACK1 (Figure 7a ). We found that the A B Figure 6 Src phosphorylation of RACK1 in the sixth WD repeat. A series of N-and C-terminal truncated RACK1 mutants were generated. (a) Left column: Src phosphorylation of truncated RACK1 mutants in vitro. Truncated RACK1 mutants or full-length, wild-type RACK1 (1 -317) were expressed as GST fusion proteins and analysed for phosphorylation by purified Src in an in vitro protein kinase assay. Right column: Src phosphorylation of truncated RACK1 mutants in vivo. CHO cells were cotransfected with Src and wild-type or mutant RACK1. Cells were treated with PMA for 15 min. Proteins were immunoprecipitated with anti-phosphotyrosine and subjected to immunoblot analysis with anti-RACK1. Data on levels of Src, mutant RACK1 and tyrosine-phosphorylated mutant RACK were quantified by scanning densitometry of bands. Because the amount of Src and mutant RACK1 protein expressed in cells varied with each tranfection, the phosphotyrosine signals were normalized to the amount of HA -RACK1 and Src expressed. Results were then compared to those for wild-type HA -RACK1. Results were similar for duplicate transfections for each RACK1 mutant, and for two independent experiments performed. (+): RACK1 was tyrosine phosphorylated; ( -): RACK1 was not tyrosine phosphorylated; (NT): not tested. (b) Src phosphorylation of RACK1 mutants in vivo. CHO cells were co-transfected with Src and wild-type or mutant RACK1, and treated with PMA as described above. Cell lysates were subjected to immunoblot analysis with anti-phosphotyrosine. Predicted molecular masses (kDa) of RACK1 proteins: 1 -317 (full-length), 35; 1 -258, 28; 1 -225, 25; 1 -183, 20; 1 -125, 14; 1 -97, 11 RACK1 mutants that contained phenylalanine at positions 228 and 246 (Y140-302F, Y140-246F and Y228-302F), were not phosphorylated on tyrosine by Src. In contrast, the RACK1 mutants that contained tyrosine at either one (Y246F or Y228F; Figure 6b , lanes 7 and 8 respectively) or both (Y52-194, 302F) of these positions, were phosphorylated on tyrosine by Src. Thus, Src phosphorylates RACK1 on Tyr 228 and/or 246. Previously, we showed that Tyr 228 and/or 246, when phosphorylated, interact with Src's SH2 domain .
To determine whether the Src substrate and binding sites in RACK1 have been conserved during eukaryotic evolution, we compared RACK1 sequences from eight species (human, rat, chicken, zebrafish, fly, tobacco, mold and yeast). We found that all six tyrosines in RACK1 are highly conserved from one species to another (data not shown). Moreover, the sequence flanking Tyr 246 is highly conserved from yeast to human (Figure 7b ). The sequence flanking Tyr 228 is less well conserved (Figure 7b) , and the sequence flanking other tyrosines in RACK1 is not conserved between species (data not shown). Thus, the Src substrate and binding sites in RACK1, and the sequences that flank them, have been conserved during eukaryotic evolution.
Discussion
This study shows that: (1) RACK1 is a Src substrate; (2) Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation; and (3) Src phosphorylates RACK1 in the sixth WD repeat, on highly-conserved Tyr 228 and/ or Tyr 246. Evidence that RACK1 is a Src substrate is that Src and not the Abl, EGFR or PDGFR tyrosine kinases phosphorylated RACK1 in vitro (Figure 1) , and that kinase-active forms of phosphorylated endogenous RACK1 in vivo (Figures 2 and 3 ). Evidence that Src activity is necessary for the tyrosine phosphorylation of RACK1 that occurs following PKC activation is that kinaseactive forms of Src phosphorylated RACK1 following PMA stimulation, whereas kinase-inactive K297M Src did not (Figure 4a ). Evidence that Src activity is required for the binding of RACK1 to Src's SH2 domain that occurs following PKC activation is that kinase-active forms of Src bound to RACK1 following PMA stimulation, whereas kinase-inactive K297M Src, and a Src mutant containing a small deletion in the phosphotyrosine-binding pocket of the SH2 domain, did not (Figure 4b ). Evidence that Src phosphorylates RACK1 in the sixth WD repeat is that all truncated RACK1 mutants tested that contained the sixth WD repeat were phosphorylated by Src (both in vivo and in vitro), whereas all mutants that lacked the sixth WD repeat were not (Figures 5 and 6 ). Finally, evidence that Src phosphorylates RACK1 on Tyr 228 and/or Tyr 246 is that all RACK1 mutants tested that contained tyrosine at either one or both of those positions were phosphorylated by Src, whereas all RACK1 mutants that contained phenylalanine at both position 228 and 246 were not (Figure 7a) .
The findings reported here extend our previous findings that PKC activation induces the intracellular movement and co-localization of RACK1 and Src, and the tyrosine phosphorylation of RACK1 . They provide new information about one kinase involved in the tyrosine phosphorylation of RACK1. Other findings, demonstrating that RACK1 interacts with the receptor tyrosine phosphatase PTPm, and that this interaction is disrupted by the presence of constitutively-active Src (Mourton et al., 2001) , support our findings that RACK1 is tyrosine phos-A B Figure 7 Src phosphorylation of RACK1 on highly-conserved Tyr 228 and/or Tyr 246. (a) Src phosphorylation of RACK1 on Tyr 228 and/or 246. Site-directed mutagenesis of RACK1 was performed, substituting phenylalanine for tyrosine at individual and multiple sites. RACK1 mutants were co-expressed with Src in CHO cells. Cells were treated with sodium vanadate for 30 min and with PMA for 15 min prior to lysis. Proteins were immunoprecipitated with anti-phosphotyrosine and subjected to immunoblot analysis with anti-RACK1. Data were analysed as described in the legend to Figure 6 . Results were similar for duplicate plates of cells co-transfected with Src and each RACK1 mutant, and for two independent experiments performed. (b) Conservation of Tyr 228 and Tyr 246 during eukaryotic evolution. RACK1 sequences from eight eukaryotic organisms were aligned. Comparative sequence for the sixth WD repeat are shown phorylated and that Src is one tyrosine kinase that phosphorylates RACK1. Moreover, the observation that, as cell density increases, cytoplasmic RACK1 translocates to the plasma membrane and to cell -cell contacts where it associates with PTPm (Mourton et al., 2001) , resembles our observation that, upon PKC activation, RACK1 translocates to the plasma membrane where it co-localizes with Src . Together, the results indicate that, following various stimuli, RACK1 moves to the plasma membrane and associates with tyrosine kinases and phosphatases. Our findings that Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the association of RACK1 and Src that occur following PKC activation, resembles other findings that PTPm is necessary for the recruitment of RACK1 to both the plasma membrane and cell -cell contacts that occurs as cell density increases (Mourton et al., 2001) . Together, the findings indicate that tyrosine kinases and phosphatases play an important role in recruiting RACK1 to the plasma membrane and other intracellular sites, and that tyrosine phosphorylation and dephosphorylation of RACK1 at these sites is an important mechanism of protein -protein interaction and signal transduction.
RACK1 is a member of an ancient family of regulatory proteins made up of highly-conserved repeat units ending in Trp-Asp (WD) (Neer et al., 1994; Neer and Smith, 1996) . Although WD-repeat proteins are known to be serine/threonine phosphorylated (Chen et al., 1995) , to the best of our knowledge, RACK1 is the first family member shown to be tyrosine phosphorylated. We think that tyrosine phosphorylation of RACK1 and other family members may be important 'switches' that link these molecules to other signaling molecules and relay signals across many pathways. Because each WDrepeat protein contains multiple WD domains and multiple tyrosines, the 'switches' may be many, and the signals may be diverse and amplified.
Our in vitro results show that the PDGFR tyrosine kinase does not directly phosphorylate RACK1 (Figure 1 ). However, serum or PDGF treatment of cells enhances both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src . Moreover, Src, PLC-g1 and rasGAP are all known to associate via their SH2 domains with both the PDGFR (following PDGF stimulation) and with RACK1 . Together, the results indicate that, while RACK1 is not directly phosphorylated by the PDGFR, it is involved in PDGF-stimulated mitogenic signaling pathways downstream of the receptor. One possible sequence of events is that activation of the PDGFR leads to activation of Src which then phosphorylates RACK1. Once RACK1 is tyrosine phosphorylated, it binds to the SH2 domains of Src, PLC-g1, rasGAP and other signaling molecules and, in turn, regulates their activity. RACK1 could inhibit Src kinase activity by inducing a conformational change in Src when it binds, by blocking Src from phosphorylating downstream targets and/or by competing with the PDGFR for binding to Src's SH2 domain, thereby dissociating Src from the PDGFR and consequently, the mechanism by which Src is activated. PTPm and possibly other tyrosine phosphatases could, in turn, dephosphorylate RACK1, thereby dissociating RACK1 from Src and other signaling molecules.
Our previous findings that serum or PDGF stimulation or PKC activation enhance both the tyrosine phosphorylation of RACK1 and the binding of phosphotyrosines 228 and/or 247 in RACK1 to Src's SH2 domain Pellicena et al., 1998; Zhou et al., 1995) .
A diverse phage library expressing tyrosine-containing peptides was used to determine preferred substrate sequences for Src-related tyrosine kinases (Schmitz et al., 1996) . One advantage of this approach was that all 20 amino acids were included in the library, whereas previously described chemical libraries were lacking tryptophan, tyrosine, serine, threonine and cysteine. Using the phage display technique, Src was found to prefer sites containing tryptophan or glycine in position +1 and leucine or isoleucine in position -1 relative to the tyrosine. In another approach, using a similar, complete amino acid, combinatorial library screening, similar results were found: tryptophan was important in position +1 and isoleucine in position -1 to the tyrosine (Lou et al., 1996) . Our search of the amino acid sequence flanking Tyr 228 and 246 of RACK1 from eight species (ranging from yeast to human) revealed that, in all eight species, Tyr 246 contains a tyrptophan at position +1 and Tyr 228 contains a leucine at position -1 (Figure 7b) . Thus, the sequence of RACK1 surrounding both Tyr 228 and 246 contain preferred substrate sequences for Src tyrosine kinases.
Here, we find that Src can phosphorylate either Y228 or Y246, or possibly both tyrosines on RACK1. We were not able to determine which site was a better substrate site for Src because both the Y228F and the Y246F RACK1 mutants were phosphorylated by Src ( Figure 7a ). Moreover, both tyrosines are flanked by preferred substrate sequence (Figure 7b , and as discussed above). Previously, we found by peptide competition assays that Src's SH2 domain can bind to either phosphotyrosine 228 or 246 on RACK1 . However, our mutational analyses revealed that phosphorylation of Y246 is essential for RACK1 binding to Src, whereas phosphorylation of Y228 is not . Thus, Y246 is probably the primary, and Y228 is a secondary Src substrate and binding site on RACK1. Perhaps either Y246 or Y228 alone can serve as a Src substrate and a Src SH2 binding site, but normally only Y246 does so in cells.
In summary, we have shown that RACK1 is a Src substrate. Moreover, Src activity is necessary for both the tyrosine phosphorylation of RACK1 and the binding of RACK1 to Src's SH2 domain that occur following PKC activation. Src phosphorylates RACK1 on Tyr 228 and/or 246, highly-conserved tyrosines located in the sixth WD repeat that interact with Src's SH2 domain. We believe that RACK1 is an important Src substrate that signals downstream of growth factor receptor tyrosine kinases and is involved in the regulation of Src function and cell growth.
Materials and methods
Cell Culture
(BioRad, Hercules, CA, USA) for 2 h at 60 V (Cartwright et al., 1985 (Cartwright et al., , 1986 (Cartwright et al., , 1987 (Cartwright et al., , 1990 Park and Cartwright, 1995) . Protein binding sites on the membranes were blocked by incubating membranes overnight in TNT buffer (10 mM TrisHCl (pH 7.5), 100 mM sodium chloride, 0.1% (v/v) Tween 20 (Sigma)) containing 3% nonfat, powdered milk (blocking buffer). Membranes were incubated with MAb RACK1 (0.08 mg/ml), affinity-purified MAb 327 ascites (2 mg/ml) or MAb PY20 (0.08 mg/ml) for 1 h, washed in TNT buffer with changes every 5 min for 30 min, and incubated with horseradish peroxidase-conjugated donkey anti-mouse IgM (Zymed, San Francisco, CA, USA) for RACK1 blots or goat anti-mouse IgG (BioRad) for MAb 327 or PY20 blots Park and Cartwright, 1995) . Proteins were detected by enhanced chemiluminescence (ECL) (Amersham, Arlington Heights, IL, USA) according to the manufacturer's protocol.
GST-fusion protein assays
Cultures of Escherichia coli DH5a containing pGEX-Src-SH2 or pGEX RACK1 plasmids were induced with 0.1 mM isopropyl-b-D-thiogalactopyranoside (United States Biochemical, Cleveland, OH, USA) for 3 h at 308C as described ). Bacteria were harvested, resuspended in Tris-buffered saline (TBS) containing 1% Triton X-100 and 100 mM EDTA and sonicated. After centrifugation at 12 000 g for 10 min to remove debris, the supernatant was incubated with glutathione-agarose beads (Sigma) for 2 h at 48C with agitation. Beads were washed three times with TBS. GST fusion proteins were eluted by the addition of 100 mM Tris-pH 8.0, 120 mM NaCl and 20 mM glutathione and dialyzed four times against TBS.
Purified GST fusion proteins (1 -5 mg) were incubated with purified kinases or Src immunoprecipitates and subjected to in vitro protein kinase assays Park and Cartwright, 1995) . Other GST fusion proteins were incubated with cell lysates for 3 h at 48C as described . Protein complexes were collected with the addition of 30 ml of glutathione beads, washed four times in buffer containing 0.5% Nonidet P-40 (NP-40), 20 mM Tris pH-8.0, 100 mM sodium chloride (NaCl) and 1 mM EDTA, and boiled in sodium dodecyl sulphate (SDS) sample buffer. Proteins were resolved by SDS -PAGE, subjected to immunoblot analysis and detected by ECL.
Construction and expression of RACK1 mutants
N-terminal truncation mutants of RACK1: 42 -317 (5.1), 94 -317 (5.2), 138 -317(5.3), 181 -317 (5.4) , and 223 -317 (5.5) were made by PCR amplification using pcDNA3 RACK1 as the template, a common 3' primer (CCCGCGGCCGCGGGACCCAAGCTTGGTACC) and one of the following 5' primers: 5.1: GGATCCGGATC-CATGTGGAAACTGACCAGG; 5.2: GGATCCGGATCC-ATGACGGGCACCACCACG; 5.3: GGATCCGGATCCA-TGGTGTGCAAATACACT; 5.4: GGATCCGGATCCAT-GAACTGCAAGCTGAAG; 5.5: GGATTCCGGATCCAT-GAACGAAGGCAAACAC.
The five PCR fragments were subcloned into pcDNA3 to create pcDNA3 -RACK1-5.1, 5.2, 5.3, 5.4 and 5.5. RACK1 mutant 54 -317 was constructed by digesting full length pcDNA3 -RACK1 with EcoRI, thus cleaving the N-terminal 1 -54 fragment, and reannealing the cDNA. RACK1 mutant 54 -292 was made by partial digestion of pcDNA3-RACK1 54 -317 with BamHI. RACK1 mutant 54 -183 was constructed by complete digestion of pcDNA3-RACK1 54 -317 with XbaI. C-terminal RACK1 mutants: 1 -258, 1 -225, 1 -125, 1 -97 and 1 -36 were synthesized by PCR amplification using pcDNA3 -RACK1 as the template, CTGGTTCCGCGTGGATCCCCGAAT as the 5' primer, and one of the following 3' primers: 1 -258: AGCG-GCCGCTTTCTTGCTTCAGTTCATC; 1 -225: AGCGG-CCGCTTTTGCCTTCGTTGAGATC; 1 -125: AGCGGCC-GCTCAGCTTGCAGTTAGCCAG; 1 -97: AGCGGCCGC-TTTTGCACACACCCAGGGT; 1 -36: AGCGGCCGCT-GGTGGTGCCCGTTGTG.
Oligonucleotide-directed mutagenesis was used to substitute phenylalanine for tyrosine at residue 52, 140, 194, 228, 246 and/ or 302 of RACK1, utilizing the Transformer SiteDirected Mutagenesis Kit according to the manufacturer's protocol (Clontech, Palo Alto, CA, USA), and as previously described . The sequences of all RACK1 mutants were confirmed by automated DNA sequencing (Protein and Nucleic Acid Facility, Stanford University, Stanford, CA, USA). RACK1 mutants were subcloned into pGEX-3X vector for production of GST fusion proteins or into pcDNA3 vector for expression in mammalian cell lines.
Transfection assays
CHO cells were transfected with pcDNA3, pcDNA3-HA -RACK1, or pcDNA3-HA -RACK1 (wild-type or mutant) and pcDNA3src (wild-type or mutant) using lipofectamine (Gibco -BRL) according to the manufacturer's protocol and as described . Briefly, 2610 5 cells were seeded in six-well plates in Ham's F-12 medium containing 10% FBS. Twenty-four hours later, transfections were performed using 0.5 to 1 mg of plasmid DNA and 10 ml of lipofectamine in serum-free media. Five hours later, cells were placed in fresh media containing 10% FBS. Cells were lysed 48 h after transfection. Cells were treated with PMA (10 ng/ml) (Gibco -BRL) for 15 min prior to lysis, as previously described .
Tyrosine phosphorylation of HA -RACK1 mutants by Src in vivo
To assess tyrosine phosphorylation of HA -RACK1 mutants by Src in vivo, CHO cells were co-transfected with Src and mutant HA -RACK1 and treated with sodium vanadate (100 mM) (Sigma) for 30 min and with PMA (10 ng/ml) for 15 min prior to lysis . Cells harvested with trypsin for 2 min, collected by centrifugation and lysed in boiling SDS sample buffer. Lysates were divided into three equal parts, which were loaded on three separate gels and subjected to immunoblot analysis with anti-Src, anti-RACK1 and anti-phosophotyrosine. Data on levels of Src, mutant HA -RACK1 and tyrosine-phosphorylated mutant HA -RACK1 were quantified by scanning densitometry of bands. Because the amounts of Src and mutant HA -RACK1 protein expressed in cells varied with each transfection, the phosphotyrosine signals were normalized to the amount of HA -RACK1 and Src expressed. Results were then compared to those for wild-type HA -RACK1.
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